Sanofi Pasteur, a Sanofi Company
Sanofi Pasteur, a Sanofi Company
Explore linked clinical trials.14 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, vector-borne disease, viral hemorrhagic fever, viral infectious disease, yellow fever | Active, not recruiting | Phase 2 | 2026-09-03 | NCT04942210 | |
| Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as Toddlers | Healthy Volunteers; Meningococcal Immunisation | Active, not recruiting | Phase 3 | 2026-08-28 | NCT04936685 | |
| Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-21 | NCT06316297 | |
| Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne | Acneiform Eruptions, Skin and Connective Tissue Diseases, acne, sebaceous gland disorder, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-07-09 | NCT07013747 | |
| A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years | DNA Virus Infections, Epstein-Barr virus infection, Herpesviridae infectious disease, Infections, Tumor Virus Infections, viral infectious disease | Active, not recruiting | Not stated | 2026-06-11 | NCT07536048 | |
| Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, vector-borne disease, viral hemorrhagic fever, viral infectious disease, yellow fever | Active, not recruiting | Phase 2 | 2026-06-01 | NCT05011123 | |
| Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age | Pneumococcal Immunization | Active, not recruiting | Phase 3 | 2026-04-22 | NCT06736041 | |
| Dengvaxia US Pregnancy Registry | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-01-21 | NCT04486638 | |
| Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants | Healthy Volunteers; Meningococcal Immunization | Active, not recruiting | Phase 1 / Phase 2 | 2026-01-20 | NCT06647407 | |
| Impact of FLU Vaccination on Nasal Resident Memory Immune Responses and Peripheral Respiratory-tropic Memory Immune Responses | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Active, not recruiting | Phase 4 | 2025-12-30 | NCT06824779 | |
| Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older | Infections, Mononegavirales infectious disease, Paramyxoviridae infectious disease, Pneumovirus Infections, RNA Virus Infections, respiratory syncytial virus infectious disease, viral infectious disease | Active, not recruiting | Phase 1 / Phase 2 | 2025-12-11 | NCT06686654 | |
| Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US) | Bacterial Infections and Mycoses, Infections, Neisseriaceae Infections, bacterial infectious disease, gram-negative bacterial infections, meningococcal infection | Recruiting | Not stated | 2025-12-01 | NCT04843111 | |
| Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, pneumococcal infection, streptococcal infection | Active, not recruiting | Phase 3 | 2025-10-06 | NCT06838000 | |
| Surveillance of Suspected Dengue Cases for Access to Care for Subjects Identified as Seronegative or Undetermined Before Receiving CYD Dengue Vaccine in Previous Clinical Studies in Colombia | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Not stated | 2025-08-08 | NCT04113330 |